Assembly Biosciences earnings were -$39.0M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest ASMB earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$10.2M, up 15.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ASMB reported annual earnings of -$40.2M, with -34.4% growth.
Assembly Biosciences Earnings Reports & History FAQ
What were Assembly Biosciences's earnings last quarter?
Assembly Biosciences (NASDAQ: ASMB) reported Q2 2025 earnings per share (EPS) of -$1.33, up 32.83% year over year. Total ASMB earnings for the quarter were -$10.20 million. In the same quarter last year, Assembly Biosciences's earnings per share (EPS) was -$1.98.
Is Assembly Biosciences profitable or losing money?
As of the last Assembly Biosciences earnings report, Assembly Biosciences is currently losing money. Assembly Biosciences's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$38.96 million, a 14.57% decrease year over year.
What was ASMB's earnings growth in the past year?
As of Assembly Biosciences's earnings date in Q3 2025, Assembly Biosciences's earnings has grown year over year. ASMB earnings in the past year totalled -$38.96 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.